Read & Listen

Articles & Episodes

Stay informed with our expert insights and updates from our team

Play

Scenarios

Immerse in challenging situations tackling real-world problems

About

Companies

People

Mission

riskgaming

Articles, Podcasts & Scenarios

Events

Press

Brand kit

Kallyope is a biotechnology company co-founded by Lux with serial entrepreneurs Charles Zuker (co-founder of Aurora Biosciences and Senomyx), Tom Maniatis (Lasker Award winner and co-founder of Genetics Institute, New York Genome Center, ProScript Inc, and Acceleron Pharma) and Richard Axel (2004 Nobel Prize winner). Kallyope integrates cutting-edge technologies in sequencing, bioinformatics, neural imaging, cellular and molecular biology and human genetics to provide an understanding of gut-brain biology that will lead to transformational therapeutics and products that improve human health and nutrition.

industries

Biology Biochemistry

Advancing Human Health

Milestones

Lux founded: 2015

Founders

Richard Axel

Tom Maniatis

Charles Zuker

Nancy Thornberry

Lux partners

Josh Wolfe

Open Positions

Visit Website

Kallyope

Similar companies

Eikon Therapeutics

Biology + Biochemistry

Advancing Human Health

Progressing Science + Knowledge

josh-wolfe

Eikon Therapeutics is pioneering a new method of drug discovery based on tracking and measuring the movement of individual proteins in living cells.

industries

Biology Biochemistry

Advancing Human Health

Progressing Science Knowledge

Milestones

Lux investment: 2019

Founders

Eric Betzig

Robert Tjian

Luke Lavis

Xavier Darzacq

Lux partners

view company profile

{name}

Kallyope

Biology + Biochemistry

Advancing Human Health

josh-wolfe

Kallyope is a platform biotechnology company dedicated to unlocking the therapeutic and nutritional product potential of the gut-brain axis.

industries

Biology Biochemistry

Advancing Human Health

Milestones

Lux founded: 2015

Founders

Richard Axel

Tom Maniatis

Charles Zuker

Nancy Thornberry

Lux partners

view company profile

{name}

Benchling

Advancing Human Health

Progressing Science + Knowledge

brandon-reeves

Benchling is transforming research and development with the industry's most widely adopted Life Sciences R&D Cloud.

industries

Advancing Human Health

Progressing Science Knowledge

Milestones

Lux investment: 2020

Founders

Saji Wickramasekara

Ashu Singhal

Lux partners

view company profile

{name}

Recursion Pharma

Biology + Biochemistry

Advancing Human Health

Progressing Science + Knowledge

Recursion Pharma is combining high-throughput experimental biology, bioinformatics, and machine learning to rapidly identify new indications for many known drugs and shelved assets. The company completed its IPO [NASDAQ: RXRX] in 2021.

industries

Biology Biochemistry

Advancing Human Health

Progressing Science Knowledge

Milestones

Lux investment: 2016

IPO: 2021

Founders

Chris Gibson, PhD

Blake Borgeson, PhD

Dean Li, PhD

Lux partners

view company profile

{name}

Maven

Advancing Human Health

deena-shakir

Maven is the largest virtual clinic for women's and family health.

industries

Advancing Human Health

Milestones

Lux investment: 2021

Founders

Lux partners

view company profile

{name}

Auris Health

Engineering + Electronics

Advancing Human Health

Increasing Productivity + Efficiency

peter-hebert

Auris Healthis an ambitious robotics company based in Silicon Valley. Auris was acquired for up to $6.1B by Johnson & Johnson in 2019.

industries

Engineering Electronics

Advancing Human Health

Increasing Productivity Efficiency

Milestones

Lux investment: 2012

Acquired by JNJ: 2019

Founders

Fred Moll

Lux partners

view company profile

{name}

Evolutionary Scale

Biology + Biochemistry

Progressing Science + Knowledge

josh-wolfe

ESM3 is the first generative AI model for biology that simultaneously reasons over the sequence, structure, and function of proteins. This enables scientists to understand and create new proteins, making biology programmable.

industries

Biology Biochemistry

Milestones

Lux investment: 2023

Founders

Alex Rives

Tom Sercu

Sal Candido

Lux partners

view company profile

{name}

Cajal Neuroscience

Biology + Biochemistry

Advancing Human Health

Progressing Science + Knowledge

josh-wolfe,ian-peikon

Cajal Neuroscienceis a drug discovery company focused on neurodegenerative disease.

industries

Biology Biochemistry

Advancing Human Health

Progressing Science Knowledge

Milestones

Lux investment: 2020

Founders

Ian Peikon, PhD

Charles Zuker, PhD

Huda Zoghbi, MD

Tony Zador, MD, PhD

Rob Hershberg, MD, PhD

Andrew Dervan, MD

Lux partners

view company profile

{name}

Read the Riskgaming newsletter

Read

Listen to the Riskgaming podcast

We believe before others understand

New York

920 Broadway 11th Floor
New York, NY 10010

[P]

646.475.4385

[F]

646.349.2960

Silicon VAlley

1600 El Camino Real, Ste 290
Menlo Park, CA 94025

[P]

646.475.4385

[F]

646.349.2960

Media

Events

Brand assets

[E]

comms@luxcapital.com

[E]

info@luxcapital.com

Privacy & Terms

Laurence Pevsner

Nat Turner

David Yang

Kim Tran

Tess van Stekelenburg

Andrew Wilson

Tracie Rotter

Stevie Lee

Steven Brody

Shaq Vayda

Shahin Farshchi, PhD

Segolene Scarborough

Sean Traynor

Scott Rubin

Samuel Arbesman, PhD

Samantha Cho

Peter Hébert

Lindsay Morris

Lan Jiang

Josh Wolfe

Grace Isford

Deena Shakir

Debbie Elsen

Danny Crichton

Cristina Morris

Brandon Reeves

Brad Gritsch

Bibi Masara

Adam Kalish